Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Researchers say semaglutide may help reverse MASH, a progressive liver condition affecting millions of Americans.

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...

With more than 40% of U.S. adults having been diagnosed with liver disease, Virginia Commonwealth University (VCU) research suggests that there might be a way to treat fatty liver disease.

A major clinical trial reveals Wegovy a popular weight loss drug also treats serious liver disease MASH—reducing liver inflammation and scarring in most patients ...